Spatiotemporal Engineering of Cancer Immunotherapy
Name
fink-lizfink-phd-cheme-2026-thesis.pdf
Size
7.69 MB
Format
Adobe PDF
Checksum (MD5)
33e68a6b47f4c00cd7c97efb8149bae3
Author(s)
Fink, Elizabeth Anne
Advisor(s)
Wittrup, K. Dane
Date Issued
May 2026
Publisher
Massachusetts Institute of Technology
Abstract
Intratumoral immunotherapies hold promise for inducing potent, localized immune activation while limiting systemic toxicity. However, their success depends not only on the potency of the therapeutic agent, but also on the ability to control where it distributes, how long it persists, and which cells it engages with in the tumor microenvironment. This thesis explores strategies to improve the spatial and temporal control of intratumorally administered cytokine therapies, integrating protein engineering, translational development, and quantitative delivery assessment.
We first investigated how extracellular matrix-targeted anchoring strategies influence cytokine retention and immune engagement. Engineering cytokines to bind hyaluronic acid conferred a distinct mode of tissue retention compared to collagen-targeted approaches and significantly widened the therapeutic window of an intratumoral IL-12/IL-15 regimen in murine tumor models. Enhanced intratumoral biodistribution was associated with reduced toxicity and measurable modulation of the tumor immune landscape, demonstrating that the mode of cytokine retention can meaningfully shape biological outcomes.
To translate these principles into a clinically relevant setting, we develop a canine-specific CD45-targeted dual-cytokine fusion protein and evaluated it in a clinical trial for spontaneous oral malignant melanoma. Treatment was well tolerated and elicited systemic and regional immune activation. Although preliminary clinical responses were modest, the exceptional tolerability of the therapy motivates dose expansion cohorts to improve antitumor response. The ongoing trial provides a unique opportunity to interrogate mechanisms of action in a large animal model with tumor heterogeneity and immune architecture more representative of human cancers, informing future optimization of cytokine targeting, dosing, and combination strategies.
Finally, we established a workflow to quantitatively evaluate how injection technique and tumor microenvironmental factors influence intratumoral material dispersion in spontaneous canine sarcomas. Our findings reveal that commonly recommended injection strategies provide limited control over spatial distribution, and that optimizing delivery strategies should be a focus of future research in the intratumoral immunotherapy field.
Together, these studies establish a framework for rational spatiotemporal engineering of intratumoral immunotherapies. By improving our ability to localize and mechanistically understand cytokine therapies within tumors, this thesis contributes foundational principles for translating immunotherapies into clinically viable treatments.
MIT Department
Massachusetts Institute of Technology. Department of Chemical Engineering
Terms of Use
In Copyright - Educational Use Permitted
Copyright retained by author(s)
Persistent DSpace Link